Biotech

Biomarin Hemophilia Gene Therapy Advances on Strong Study Results

Biomarin Hemophilia Gene Therapy Advances on Strong Study Results

Amgen Still Has Many Ways to Win

Amgen Still Has Many Ways to Win

Jim Cramer Likes UTX, Says Gilead Has Peaked, Sees a Bottom for Oil

Jim Cramer Likes UTX, Says Gilead Has Peaked, Sees a Bottom for Oil

DuPont Beats Earnings Ahead of Dow Chemical Merger

DuPont Beats Earnings Ahead of Dow Chemical Merger

Gilead Lowers Product Sales Guidance on Weak Hepatitis C Sales

Gilead Lowers Product Sales Guidance on Weak Hepatitis C Sales

Gilead Readying for Earnings Report

Gilead Readying for Earnings Report

PTC Therapeutics Duchenne Drug Stuck on Conditional Approval Status in Europe

PTC Therapeutics Duchenne Drug Stuck on Conditional Approval Status in Europe

What to Watch This Week: Apple, Facebook, Alphabet Report Earnings; Federal Reserve Meeting

What to Watch This Week: Apple, Facebook, Alphabet Report Earnings; Federal Reserve Meeting

Trade These 5 Biotech Breakouts Now for Big Gains

Trade These 5 Biotech Breakouts Now for Big Gains

Jim Cramer on Tesla: Elon Musk is a Visionary, Numbers Tell a Different Story

Jim Cramer on Tesla: Elon Musk is a Visionary, Numbers Tell a Different Story